The metabolic syndrome: Prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 5, 2007, Pages 349-357

  Halldin, M ^a   Rosell, M ^a   de Faire, U ^a,b   Hellenius M L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cross sectional study; Lifestyle; Metabolic syndrome; Physical activity

Indexed keywords

LIPID;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; FITNESS; HEALTH SURVEY; HUMAN; LIFESTYLE; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; RISK; RISK FACTOR; SWEDEN;

ACTIVITIES OF DAILY LIVING; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LIFE STYLE; LIPID METABOLISM; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PHYSICAL FITNESS; PREVALENCE; RISK FACTORS; SWEDEN;

EID: 34249941041     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.01.002     Document Type: Article

References (56)

1. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 73 (2003) 2395-2411
2. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
3. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation 106 (2002) 3143-3421
5. Ford E.S. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33 (2004) 333-350
6. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
7. Aguilar-Salinas C.A., Rojas R., Gomez-Perez F.J., Valles V., Rios-Torres J.M., Franco A., et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 35 (2004) 76-81
8. Ilanne-Parikka P., Eriksson J.G., Lindstrom J., Hamalainen H., Keinanen-Kiukaanniemi S., Laakso M., et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the diabetes prevention study cohort. Diabetes Care 27 (2004) 2135-2140
9. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., and Pyorala K. DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
10. Lawlor D.A., Ebrahim S., and Smith G.D. The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study. Diabet Med 21 (2004) 906-913
11. Laaksonen D.E., Lakka H.M., Salonen J.T., Niskanen L.K., Rauramaa R., and Lakka T.A. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 25 (2002) 1612-1618
12. Lakka T.A., Laaksonen D.E., Lakka H.M., Mannikko N., Niskanen L.K., Rauramaa R., et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 35 (2003) 1279-1286
13. Rennie K.L., McCarthy N., Yazdgerdi S., Marmot M., and Brunner E. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol 32 (2003) 600-606
14. Ford E.S., Kohl III H.W., Mokdad A.H., and Ajani U.A. Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. Obes Res 13 (2005) 608-614
15. Onat A., Ceyhan K., Basar O., Erer B., Toprak S., and Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
16. Carroll S., and Dudfield M. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med 34 (2004) 371-418
17. Barnard R.J., Aronson W.J., Tymchuk C.N., and Ngo T.H. Prostate cancer: another aspect of the insulin-resistance syndrome?. Obes Rev 3 (2002) 303-308
18. Sinagra D., Amato C., Scarpilta A.M., Brigandi M., Amato M., Saura G., et al. Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci 6 (2002) 55-59
19. Leineweber C., Kecklund G., Akerstedt T., Janszky I., and Orth-Gomer K. Snoring and the metabolic syndrome in women. Sleep Med 4 (2003) 531-536
20. Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., and Wilding J.P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
21. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
22. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
23. Fossati P., Prencipe L., and Berti G. Use of 3,5-dichloro-2 hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 26 (1980) 227-231
24. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
25. Hemker H.C., Kop J., and Willems G.M. Kinetic aspects of the interaction of blood clotting enzymes. VIII. The relation between clotting time and clotting velocity. Thromb Haemost 41 (1979) 309-313
26. Becker U., Bartl K., and Wahlefeld A.W. A functional photometric assay for plasma fibrinogen. Thromb Res 35 (1984) 475-484
27. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22 (1969) 158-161
28. Tibblin G., Cato K., and Svardsudd K. Goteborg quality of life study of men born in 1913 and 1923-age, sex, job satisfaction and cardiovascular diseases. Scand J Prim Health Care Suppl 1 (1990) 39-45
29. Hosmer D.W., and Lemeshow S. Applied logistic regression (1989), Wiley, New York
30. Steinbaum S.R. The metabolic syndrome: an emerging health epidemic in women. Prog Cardiovasc Dis 46 (2004) 321-336
31. Rosengren A., Eriksson H., Larsson B., Svardsudd K., Tibblin G., Welin L., et al. Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943. J Intern Med 247 (2000) 111-118
32. Riserus U., Arnlov J., Brismar K., Zethelius B., Berglund L., and Vessby B. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care 27 (2004) 2041-2046
33. Janssen I., Katzmarzyk P.T., and Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79 (2004) 379-384
34. Palaniappan L., Carnethon M.R., Wang Y., Hanley A.J., Fortmann S.P., Haffner S.M., et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27 (2004) 788-793
35. Hammarsten J., and Hogstedt B. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press 13 (2004) 47-55
36. Guastamacchia E., Resta F., Triggiani V., Liso A., Licchelli B., Ghiyasaldin S., et al. Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors. Curr Drug Targets Immune Endocr Metabol Disord 4 (2004) 59-66
37. Furberg A.S., Veierod M.B., Wilsgaard T., Bernstein L., and Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96 (2004) 1152-1160
38. Colangelo L.A., Gapstur S.M., Gann P.H., Dyer A.R., and Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11 (2002) 385-391
39. Boyd D.B. Insulin and cancer. Integr Cancer Ther 2 (2003) 315-329
40. Kaaks R., and Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60 (2001) 91-106
41. Lindstrom J., Eriksson J.G., Valle T.T., Aunola S., Cepaitis Z., Hakumaki M., et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish diabetes prevention study: results from a randomized clinical trial. J Am Soc Nephrol 14 (2003) S108-S113
42. Gutierrez-Fisac J.L., Guallar-Castillon P., Diez-Ganan L., Lopez Garcia E., Banegas Banegas J.R., and Artalejo F.R. Work-related physical activity is not associated with body mass index and obesity. Obes Res 10 (2002) 270-276
43. Yarnell J., Yu S., McCrum E., Arveiler D., Hass B., Dallongeville J., et al. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 34 (2005) 268-275
44. Silventoinen K., Pankow J., Jousilahti P., Hu G., and Tuomilehto J. Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol 34 (2005) 327-334
45. Hu G., Qiao Q., Silventoinen K., Eriksson J.G., Jousilahti P., Lindstrom J., et al. Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women. Diabetologia 46 (2003) 322-329
46. Haapanen N., Miilunpalo S., Vuori I., Oja P., and Pasanen M. Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women. Int J Epidemiol 26 (1997) 739-747
47. Helmrich S.P., Ragland D.R., Leung R.W., and Paffenbarger Jr. R.S. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325 (1991) 147-152
48. Perry I.J., Wannamethee S.G., Walker M.K., Thomson A.G., Whincup P.H., and Shaper A.G. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 310 (1995) 560-564
49. Hu F.B., Sigal R.J., Rich-Edwards J.W., Colditz G.A., Solomon C.G., Willett W.C., et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 282 (1999) 1433-1439
50. Brunner E.J., Marmot M.G., Nanchahal K., Shipley M.J., Stansfeld S.A., Juneja M., et al. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 40 (1997) 1341-1349
51. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2 (2001) 73-86
52. Ford E.S., Mokdad A.H., Giles W.H., and Brown D.W. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52 (2003) 2346-2352
53. Rosell M., De Faire U., and Hellenius M.L. Low prevalence of the metabolic syndrome in wine drinkers-is it the alcohol beverage or the lifestyle?. Eur J Clin Nutr 57 (2003) 227-234
54. Lichtman S.W., Pisarska K., Berman E.R., Pestone M., Dowling H., Offenbacher E., et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 327 (1992) 1893-1898
55. Dishman R.K., Darracott C.R., and Lambert L.T. Failure to generalize determinants of self-reported physical activity to a motion sensor. Med Sci Sports Exerc 24 (1992) 904-910
56. Wolf A.M., Hunter D.J., Colditz G.A., Manson J.E., Stampfer M.J., Corsano K.A., et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23 (1994) 991-999